NRW.BANK
VC Fund
Düsseldorf, Germany
NRW.BANK is a VC fund in Düsseldorf focused on Information Technology and Software. NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
- Total investments:
- 136
- Last investment:
- Lead investor:
- 24%
- Fund size:
- $163M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries NRW.BANK invests in
Stages NRW.BANK invests in
Countries NRW.BANK invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $219k–$7.7M
- Series A
- $2.4M–$36M
- Series B
- $3.8M–$71M
Investment Focus
Industry
- Information Technology 16 (12%)
- Software 15 (11%)
- Biotechnology 13 (10%)
- Health Care 12 (9%)
- Medical 9 (7%)
Stage
- Seed 24 (18%)
- Series A 18 (13%)
- Series B 15 (11%)
- Pre-Seed 14 (10%)
- Funding Round 14 (10%)
Country
- Germany 74 (54%)
- United States 2 (1%)
- France 1 (1%)
- Switzerland 1 (1%)
- United Kingdom 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aristotelis Nastos
Head of Life Sciences & Cleantech
|
Head of Life Sciences & Cleantech | Total investments: 3 | Find email | |
Claas Heise
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
Dietrich Suhlrie
Member of the Managing Board
|
Member of the Managing Board | Total investments: 0 | Find email | |
Eckhard Forst
Chairman of the Managing Board
|
Chairman of the Managing Board | Total investments: 0 | Find email | |
Gabriele Pantring
Member of the Managing Board
|
Member of the Managing Board | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PhageStack
|
PhageStack GmbH develops a computational platform that applies machine learning to screen, identify, and analyze specific bacteriophages. This technical infrastructure is built to help research partners accelerate the discovery of targeted biological options against antibiotic-resistant bacteria. | Pre-Seed / Sep 09, 2026 | |
skylance
|
Skylance develops counter-unmanned aerial systems for military and public-security users. Its products include close-range kinetic interceptors designed for Class 1 drones and a modular launcher that supports shoulder-mounted, tripod, and vehicle-integrated configurations. The company describes its systems as software-defined and compatible withexisting command-and-control structures. Its stated operating range for close-range interception is 100 to 1,200 meters. | $1.2M / Seed / Sep 03, 2026 | |
ag-tech.systems
|
ag-tech.systems GmbH designs and manufactures tractor-mounted agricultural machinery that utilizes high-voltage electricity and a specialized conductive fluid to eliminate weeds and dry crops without synthetic chemicals. Their core value proposition centers on delivering a scalable, weather-independent alternative to chemical herbicides, enablingresidue-free harvesting and helping growers align with modern pesticide reduction regulations. The company monetizes its technology via outright machine sales, direct equipment rentals, and commercial leasing structures aimed at both private farmers and third-party service operators. | Seed / Aug 21, 2026 | |
amber
|
info@amberoad.aiambeRoad is developing an intelligent enterprise search engine to help employees to find all relevant documents easily and quickly by integrating all company internal data sources into one search engine. Our solution allows access to all company-wide files from anywhere. Even if you don't exactly know what you are lookingfor, our cutting-edge AI will know because of a range of features implemented in our software.No need to tag documents manually, all in milliseconds - only one search request away. | $8.1M / Series A / Aug 17, 2026 | |
ENTRYZERO
|
ENTRYZERO is a cybersecurity startup that develops an AI-powered software platform specializing in Threat Exposure Management,the company helps organizations continuously monitor their digital attack surface from a hacker’s perspective to identify and mitigatevulnerabilities automatically. | Seed / Jun 25, 2026 | |
Nuclidium
|
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. | $33.6M / Series B / May 28, 2026 | |
eleQtron
|
eleQtron creates and operates quantum computers based on trapped ions, radio frequency control, and Magnetic Gradient Induced Coupling (MAGIC). It also puts forward novel ideas for scalable quantum processors based on RF-controlled trapped ions. eleQtron will run MAGIC quantum computers and provide quantum computing performance on a subscriptionbasis. | $66.6M / Series A / May 05, 2026 | |
odacova
|
Odacova is a SaaS company that provides individualized nutrition for corporate cafeterias and employee eating, utilizing web, Android, and iOS platforms. | Seed / Apr 28, 2026 | |
BioThrust
|
BioThrust develops customized gassing solutions for bioreactors. | Pre-Seed / Apr 23, 2026 | |
Cellbox Solutions
|
Cellbox Solutions is a young technology company that focuses on innovative logistic solutions for the global BioMed industry. | $4.1M / Series A / Mar 05, 2026 | |
| See all 136 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does NRW.BANK invest in?
NRW.BANK invests primarily in Information Technology, Software and Biotechnology startups, most often at Seed and Series A stage. Most of the 136 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is NRW.BANK's check size?
NRW.BANK typically joins rounds of $219k–$7.7M at Seed, $2.4M–$36M at Series A and $3.8M–$71M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NRW.BANK participates in.
How do I contact NRW.BANK?
Public channels for NRW.BANK include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NRW.BANK?
The team at NRW.BANK includes Aristotelis Nastos (Head of Life Sciences & Cleantech), Claas Heise (Executive Director) and Dietrich Suhlrie (Member of the Managing Board), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
